Yahoo Malaysia Web Search

Search results

  1. Dr. Teper is the principal founder of Cytovia Therapeutics. He established the strategic vision of the company and secured the key foundation product and technology acquisitions. Dr. Teper brings extensive experience as a biopharma entrepreneur, corporate executive, and management consultant.

  2. Dr. Teper is the principal founder of Cytovia Therapeutics. He established the strategic vision of the company and secured the key foundation product and technology acquisitions. Dr. Teper brings extensive experience as a biopharma entrepreneur, corporate executive, and management consultant.

  3. Dr. Teper is the Founder, Chairman, and Chief Executive Officer of NAYA Biosciences. He has over 30 years of leadership experience as a biopharma entrepreneur, corporate executive, and management consultant.

  4. Daniel Teper, PharmD, MBA. SVP, Head of R&D. Tony Arulanandam, DVM, PhD

  5. May 14, 2021 · Cytovia Therapeutics aims to accelerate patient access to transformational cell therapies and immunotherapies, addressing several of the most challenging unmet medical needs in cancer.

  6. Watch Cytovia CEO Dr. Daniel Teper's Presentation at the Recent Jefferies Cell & Genetic Medicine Summit in New York City

  7. Apr 24, 2017 · Daniel Teper, Pharm.D., has stepped down immediately as CEO of New York biotech Immune Pharma as he looks to head up its new oncology spinoff.